📰 **Kiniksa Pharma Jumps On Q1 Revenue Growth; Lifts FY26 Revenue Guidance **

(RTTNews) - Kiniksa Pharmaceuticals International, plc (KNSA), a biopharmaceutical company, reported first-quarter 2026 financial results reflecting revenue growth and improved earnings. In addition, the firm raised its full-year 2026 ARCALYST-based net product revenue guidance a...

🔗 https://www.nasdaq.com/articles/kiniksa-pharma-jumps-q1-revenue-growth-lifts-fy26-revenue-guidance

#markets #news